ヒト低域全ゲノムシーケンスのグローバル市場展望 2023年-2029年：大規模ヒト低スルー全ゲノムシーケンス（> 5 Mb）、小規模ヒト低スルー全ゲノムシーケンス（≤ 5 Mb）

■ 英語タイトル：Human Low-Pass Whole Genome Sequencing Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC12373）

■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC12373
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療
■ ページ数：68
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[ヒト低域全ゲノムシーケンスのグローバル市場展望 2023年-2029年：大規模ヒト低スルー全ゲノムシーケンス（> 5 Mb）、小規模ヒト低スルー全ゲノムシーケンス（≤ 5 Mb）]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のヒト低域全ゲノムシーケンス市場規模と予測を収録しています。・世界のヒト低域全ゲノムシーケンス市場：売上、2018年-2023年、2024年-2029年
・世界のヒト低域全ゲノムシーケンス市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のヒト低域全ゲノムシーケンス市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「大規模ヒト低スルー全ゲノムシーケンス（> 5 Mb）」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ヒト低域全ゲノムシーケンスのグローバル主要企業は、BGI、 Breda Genetics、 Azenta Life Sciences、 Thermo Fisher Scientific、 Psomagen、 Healgen Scientific、 Agilent Technologies、 Macrogen、 Veritas Genetics、 Centogene、 Nebula Genomics、 CD Genomicsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ヒト低域全ゲノムシーケンスのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のヒト低域全ゲノムシーケンス市場：タイプ別、2018年-2023年、2024年-2029年
世界のヒト低域全ゲノムシーケンス市場：タイプ別市場シェア、2022年
・大規模ヒト低スルー全ゲノムシーケンス（> 5 Mb）、小規模ヒト低スルー全ゲノムシーケンス（≤ 5 Mb）

世界のヒト低域全ゲノムシーケンス市場：用途別、2018年-2023年、2024年-2029年
世界のヒト低域全ゲノムシーケンス市場：用途別市場シェア、2022年
・医療、科学研究、その他

世界のヒト低域全ゲノムシーケンス市場：地域・国別、2018年-2023年、2024年-2029年
世界のヒト低域全ゲノムシーケンス市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるヒト低域全ゲノムシーケンスのグローバル売上、2018年-2023年
・主要企業におけるヒト低域全ゲノムシーケンスのグローバル売上シェア、2022年
・主要企業におけるヒト低域全ゲノムシーケンスのグローバル販売量、2018年-2023年
・主要企業におけるヒト低域全ゲノムシーケンスのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
BGI、 Breda Genetics、 Azenta Life Sciences、 Thermo Fisher Scientific、 Psomagen、 Healgen Scientific、 Agilent Technologies、 Macrogen、 Veritas Genetics、 Centogene、 Nebula Genomics、 CD Genomics

*************************************************************

・調査・分析レポートの概要
ヒト低域全ゲノムシーケンス市場の定義
市場セグメント
世界のヒト低域全ゲノムシーケンス市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のヒト低域全ゲノムシーケンス市場規模
世界のヒト低域全ゲノムシーケンス市場規模：2022年 VS 2029年
世界のヒト低域全ゲノムシーケンス市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのヒト低域全ゲノムシーケンスの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のヒト低域全ゲノムシーケンス製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：大規模ヒト低スルー全ゲノムシーケンス（> 5 Mb）、小規模ヒト低スルー全ゲノムシーケンス（≤ 5 Mb）
ヒト低域全ゲノムシーケンスのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：医療、科学研究、その他
ヒト低域全ゲノムシーケンスの用途別グローバル売上・予測

・地域別市場分析
地域別ヒト低域全ゲノムシーケンス市場規模 2022年と2029年
地域別ヒト低域全ゲノムシーケンス売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
BGI、 Breda Genetics、 Azenta Life Sciences、 Thermo Fisher Scientific、 Psomagen、 Healgen Scientific、 Agilent Technologies、 Macrogen、 Veritas Genetics、 Centogene、 Nebula Genomics、 CD Genomics
...

This research report provides a comprehensive analysis of the Human Low-Pass Whole Genome Sequencing market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Human Low-Pass Whole Genome Sequencing market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Human Low-Pass Whole Genome Sequencing, challenges faced by the industry, and potential opportunities for market players.
The global Human Low-Pass Whole Genome Sequencing market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Human Low-Pass Whole Genome Sequencing market presents opportunities for various stakeholders, including Medical, Scientific Research. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Human Low-Pass Whole Genome Sequencing market. Additionally, the growing consumer demand present avenues for market expansion.
The global Human Low-Pass Whole Genome Sequencing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Human Low-Pass Whole Genome Sequencing market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Human Low-Pass Whole Genome Sequencing market.
Market Overview: The report provides a comprehensive overview of the Human Low-Pass Whole Genome Sequencing market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Large Human Low-Through Whole Genome Sequencing (> 5 Mb), Small Human Low-Through Whole Genome Sequencing (≤ 5 Mb)), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Human Low-Pass Whole Genome Sequencing market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Human Low-Pass Whole Genome Sequencing market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Human Low-Pass Whole Genome Sequencing market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Human Low-Pass Whole Genome Sequencing market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Human Low-Pass Whole Genome Sequencing market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Human Low-Pass Whole Genome Sequencing market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Human Low-Pass Whole Genome Sequencing, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Human Low-Pass Whole Genome Sequencing market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Human Low-Pass Whole Genome Sequencing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
Small Human Low-Through Whole Genome Sequencing (≤ 5 Mb)
Market segment by Application
Medical
Scientific Research
Others
Global Human Low-Pass Whole Genome Sequencing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
BGI
Breda Genetics
Azenta Life Sciences
Thermo Fisher Scientific
Psomagen
Healgen Scientific
Agilent Technologies
Macrogen
Veritas Genetics
Centogene
Nebula Genomics
CD Genomics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Low-Pass Whole Genome Sequencing, market overview.
Chapter 2: Global Human Low-Pass Whole Genome Sequencing market size in revenue.
Chapter 3: Detailed analysis of Human Low-Pass Whole Genome Sequencing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Low-Pass Whole Genome Sequencing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Human Low-Pass Whole Genome Sequencing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Low-Pass Whole Genome Sequencing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Low-Pass Whole Genome Sequencing Overall Market Size
2.1 Global Human Low-Pass Whole Genome Sequencing Market Size: 2022 VS 2029
2.2 Global Human Low-Pass Whole Genome Sequencing Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Human Low-Pass Whole Genome Sequencing Players in Global Market
3.2 Top Global Human Low-Pass Whole Genome Sequencing Companies Ranked by Revenue
3.3 Global Human Low-Pass Whole Genome Sequencing Revenue by Companies
3.4 Top 3 and Top 5 Human Low-Pass Whole Genome Sequencing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Human Low-Pass Whole Genome Sequencing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Low-Pass Whole Genome Sequencing Players in Global Market
3.6.1 List of Global Tier 1 Human Low-Pass Whole Genome Sequencing Companies
3.6.2 List of Global Tier 2 and Tier 3 Human Low-Pass Whole Genome Sequencing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Human Low-Pass Whole Genome Sequencing Market Size Markets, 2022 & 2029
4.1.2 Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
4.1.3 Small Human Low-Through Whole Genome Sequencing (≤ 5 Mb)
4.2 By Type – Global Human Low-Pass Whole Genome Sequencing Revenue & Forecasts
4.2.1 By Type – Global Human Low-Pass Whole Genome Sequencing Revenue, 2018-2023
4.2.2 By Type – Global Human Low-Pass Whole Genome Sequencing Revenue, 2024-2029
4.2.3 By Type – Global Human Low-Pass Whole Genome Sequencing Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Human Low-Pass Whole Genome Sequencing Market Size, 2022 & 2029
5.1.2 Medical
5.1.3 Scientific Research
5.1.4 Others
5.2 By Application – Global Human Low-Pass Whole Genome Sequencing Revenue & Forecasts
5.2.1 By Application – Global Human Low-Pass Whole Genome Sequencing Revenue, 2018-2023
5.2.2 By Application – Global Human Low-Pass Whole Genome Sequencing Revenue, 2024-2029
5.2.3 By Application – Global Human Low-Pass Whole Genome Sequencing Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Human Low-Pass Whole Genome Sequencing Market Size, 2022 & 2029
6.2 By Region – Global Human Low-Pass Whole Genome Sequencing Revenue & Forecasts
6.2.1 By Region – Global Human Low-Pass Whole Genome Sequencing Revenue, 2018-2023
6.2.2 By Region – Global Human Low-Pass Whole Genome Sequencing Revenue, 2024-2029
6.2.3 By Region – Global Human Low-Pass Whole Genome Sequencing Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Human Low-Pass Whole Genome Sequencing Revenue, 2018-2029
6.3.2 US Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
6.3.3 Canada Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
6.3.4 Mexico Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Human Low-Pass Whole Genome Sequencing Revenue, 2018-2029
6.4.2 Germany Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
6.4.3 France Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
6.4.4 U.K. Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
6.4.5 Italy Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
6.4.6 Russia Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
6.4.7 Nordic Countries Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
6.4.8 Benelux Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Human Low-Pass Whole Genome Sequencing Revenue, 2018-2029
6.5.2 China Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
6.5.3 Japan Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
6.5.4 South Korea Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
6.5.5 Southeast Asia Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
6.5.6 India Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Human Low-Pass Whole Genome Sequencing Revenue, 2018-2029
6.6.2 Brazil Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
6.6.3 Argentina Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Human Low-Pass Whole Genome Sequencing Revenue, 2018-2029
6.7.2 Turkey Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
6.7.3 Israel Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
6.7.4 Saudi Arabia Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
6.7.5 UAE Human Low-Pass Whole Genome Sequencing Market Size, 2018-2029
7 Human Low-Pass Whole Genome Sequencing Companies Profiles
7.1 BGI
7.1.1 BGI Company Summary
7.1.2 BGI Business Overview
7.1.3 BGI Human Low-Pass Whole Genome Sequencing Major Product Offerings
7.1.4 BGI Human Low-Pass Whole Genome Sequencing Revenue in Global Market (2018-2023)
7.1.5 BGI Key News & Latest Developments
7.2 Breda Genetics
7.2.1 Breda Genetics Company Summary
7.2.2 Breda Genetics Business Overview
7.2.3 Breda Genetics Human Low-Pass Whole Genome Sequencing Major Product Offerings
7.2.4 Breda Genetics Human Low-Pass Whole Genome Sequencing Revenue in Global Market (2018-2023)
7.2.5 Breda Genetics Key News & Latest Developments
7.3 Azenta Life Sciences
7.3.1 Azenta Life Sciences Company Summary
7.3.2 Azenta Life Sciences Business Overview
7.3.3 Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Major Product Offerings
7.3.4 Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Revenue in Global Market (2018-2023)
7.3.5 Azenta Life Sciences Key News & Latest Developments
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Company Summary
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Major Product Offerings
7.4.4 Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Revenue in Global Market (2018-2023)
7.4.5 Thermo Fisher Scientific Key News & Latest Developments
7.5 Psomagen
7.5.1 Psomagen Company Summary
7.5.2 Psomagen Business Overview
7.5.3 Psomagen Human Low-Pass Whole Genome Sequencing Major Product Offerings
7.5.4 Psomagen Human Low-Pass Whole Genome Sequencing Revenue in Global Market (2018-2023)
7.5.5 Psomagen Key News & Latest Developments
7.6 Healgen Scientific
7.6.1 Healgen Scientific Company Summary
7.6.2 Healgen Scientific Business Overview
7.6.3 Healgen Scientific Human Low-Pass Whole Genome Sequencing Major Product Offerings
7.6.4 Healgen Scientific Human Low-Pass Whole Genome Sequencing Revenue in Global Market (2018-2023)
7.6.5 Healgen Scientific Key News & Latest Developments
7.7 Agilent Technologies
7.7.1 Agilent Technologies Company Summary
7.7.2 Agilent Technologies Business Overview
7.7.3 Agilent Technologies Human Low-Pass Whole Genome Sequencing Major Product Offerings
7.7.4 Agilent Technologies Human Low-Pass Whole Genome Sequencing Revenue in Global Market (2018-2023)
7.7.5 Agilent Technologies Key News & Latest Developments
7.8 Macrogen
7.8.1 Macrogen Company Summary
7.8.2 Macrogen Business Overview
7.8.3 Macrogen Human Low-Pass Whole Genome Sequencing Major Product Offerings
7.8.4 Macrogen Human Low-Pass Whole Genome Sequencing Revenue in Global Market (2018-2023)
7.8.5 Macrogen Key News & Latest Developments
7.9 Veritas Genetics
7.9.1 Veritas Genetics Company Summary
7.9.2 Veritas Genetics Business Overview
7.9.3 Veritas Genetics Human Low-Pass Whole Genome Sequencing Major Product Offerings
7.9.4 Veritas Genetics Human Low-Pass Whole Genome Sequencing Revenue in Global Market (2018-2023)
7.9.5 Veritas Genetics Key News & Latest Developments
7.10 Centogene
7.10.1 Centogene Company Summary
7.10.2 Centogene Business Overview
7.10.3 Centogene Human Low-Pass Whole Genome Sequencing Major Product Offerings
7.10.4 Centogene Human Low-Pass Whole Genome Sequencing Revenue in Global Market (2018-2023)
7.10.5 Centogene Key News & Latest Developments
7.11 Nebula Genomics
7.11.1 Nebula Genomics Company Summary
7.11.2 Nebula Genomics Business Overview
7.11.3 Nebula Genomics Human Low-Pass Whole Genome Sequencing Major Product Offerings
7.11.4 Nebula Genomics Human Low-Pass Whole Genome Sequencing Revenue in Global Market (2018-2023)
7.11.5 Nebula Genomics Key News & Latest Developments
7.12 CD Genomics
7.12.1 CD Genomics Company Summary
7.12.2 CD Genomics Business Overview
7.12.3 CD Genomics Human Low-Pass Whole Genome Sequencing Major Product Offerings
7.12.4 CD Genomics Human Low-Pass Whole Genome Sequencing Revenue in Global Market (2018-2023)
7.12.5 CD Genomics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Human Low-Pass Whole Genome Sequencing Market Opportunities & Trends in Global Market
Table 2. Human Low-Pass Whole Genome Sequencing Market Drivers in Global Market
Table 3. Human Low-Pass Whole Genome Sequencing Market Restraints in Global Market
Table 4. Key Players of Human Low-Pass Whole Genome Sequencing in Global Market
Table 5. Top Human Low-Pass Whole Genome Sequencing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Human Low-Pass Whole Genome Sequencing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Human Low-Pass Whole Genome Sequencing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Human Low-Pass Whole Genome Sequencing Product Type
Table 9. List of Global Tier 1 Human Low-Pass Whole Genome Sequencing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Low-Pass Whole Genome Sequencing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Human Low-Pass Whole Genome Sequencing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Human Low-Pass Whole Genome Sequencing Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Human Low-Pass Whole Genome Sequencing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Human Low-Pass Whole Genome Sequencing Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Human Low-Pass Whole Genome Sequencing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Human Low-Pass Whole Genome Sequencing Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2024-2029
Table 30. BGI Company Summary
Table 31. BGI Human Low-Pass Whole Genome Sequencing Product Offerings
Table 32. BGI Human Low-Pass Whole Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 33. BGI Key News & Latest Developments
Table 34. Breda Genetics Company Summary
Table 35. Breda Genetics Human Low-Pass Whole Genome Sequencing Product Offerings
Table 36. Breda Genetics Human Low-Pass Whole Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 37. Breda Genetics Key News & Latest Developments
Table 38. Azenta Life Sciences Company Summary
Table 39. Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Product Offerings
Table 40. Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 41. Azenta Life Sciences Key News & Latest Developments
Table 42. Thermo Fisher Scientific Company Summary
Table 43. Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Product Offerings
Table 44. Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 45. Thermo Fisher Scientific Key News & Latest Developments
Table 46. Psomagen Company Summary
Table 47. Psomagen Human Low-Pass Whole Genome Sequencing Product Offerings
Table 48. Psomagen Human Low-Pass Whole Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 49. Psomagen Key News & Latest Developments
Table 50. Healgen Scientific Company Summary
Table 51. Healgen Scientific Human Low-Pass Whole Genome Sequencing Product Offerings
Table 52. Healgen Scientific Human Low-Pass Whole Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 53. Healgen Scientific Key News & Latest Developments
Table 54. Agilent Technologies Company Summary
Table 55. Agilent Technologies Human Low-Pass Whole Genome Sequencing Product Offerings
Table 56. Agilent Technologies Human Low-Pass Whole Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 57. Agilent Technologies Key News & Latest Developments
Table 58. Macrogen Company Summary
Table 59. Macrogen Human Low-Pass Whole Genome Sequencing Product Offerings
Table 60. Macrogen Human Low-Pass Whole Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 61. Macrogen Key News & Latest Developments
Table 62. Veritas Genetics Company Summary
Table 63. Veritas Genetics Human Low-Pass Whole Genome Sequencing Product Offerings
Table 64. Veritas Genetics Human Low-Pass Whole Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 65. Veritas Genetics Key News & Latest Developments
Table 66. Centogene Company Summary
Table 67. Centogene Human Low-Pass Whole Genome Sequencing Product Offerings
Table 68. Centogene Human Low-Pass Whole Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 69. Centogene Key News & Latest Developments
Table 70. Nebula Genomics Company Summary
Table 71. Nebula Genomics Human Low-Pass Whole Genome Sequencing Product Offerings
Table 72. Nebula Genomics Human Low-Pass Whole Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 73. Nebula Genomics Key News & Latest Developments
Table 74. CD Genomics Company Summary
Table 75. CD Genomics Human Low-Pass Whole Genome Sequencing Product Offerings
Table 76. CD Genomics Human Low-Pass Whole Genome Sequencing Revenue (US$, Mn) & (2018-2023)
Table 77. CD Genomics Key News & Latest Developments
List of Figures
Figure 1. Human Low-Pass Whole Genome Sequencing Segment by Type in 2022
Figure 2. Human Low-Pass Whole Genome Sequencing Segment by Application in 2022
Figure 3. Global Human Low-Pass Whole Genome Sequencing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Low-Pass Whole Genome Sequencing Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Human Low-Pass Whole Genome Sequencing Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Human Low-Pass Whole Genome Sequencing Revenue in 2022
Figure 8. By Type - Global Human Low-Pass Whole Genome Sequencing Revenue Market Share, 2018-2029
Figure 9. By Application - Global Human Low-Pass Whole Genome Sequencing Revenue Market Share, 2018-2029
Figure 10. By Type - Global Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Human Low-Pass Whole Genome Sequencing Revenue Market Share, 2018-2029
Figure 12. By Application - Global Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Human Low-Pass Whole Genome Sequencing Revenue Market Share, 2018-2029
Figure 14. By Region - Global Human Low-Pass Whole Genome Sequencing Revenue Market Share, 2018-2029
Figure 15. By Country - North America Human Low-Pass Whole Genome Sequencing Revenue Market Share, 2018-2029
Figure 16. US Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Human Low-Pass Whole Genome Sequencing Revenue Market Share, 2018-2029
Figure 20. Germany Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 21. France Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Human Low-Pass Whole Genome Sequencing Revenue Market Share, 2018-2029
Figure 28. China Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 32. India Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Human Low-Pass Whole Genome Sequencing Revenue Market Share, 2018-2029
Figure 34. Brazil Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Human Low-Pass Whole Genome Sequencing Revenue Market Share, 2018-2029
Figure 37. Turkey Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Human Low-Pass Whole Genome Sequencing Revenue, (US$, Mn), 2018-2029
Figure 41. BGI Human Low-Pass Whole Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Breda Genetics Human Low-Pass Whole Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Psomagen Human Low-Pass Whole Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Healgen Scientific Human Low-Pass Whole Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Agilent Technologies Human Low-Pass Whole Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Macrogen Human Low-Pass Whole Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Veritas Genetics Human Low-Pass Whole Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Centogene Human Low-Pass Whole Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Nebula Genomics Human Low-Pass Whole Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. CD Genomics Human Low-Pass Whole Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

ヒト低域全ゲノムシーケンスのグローバル市場展望 2023年-2029年：大規模ヒト低スルー全ゲノムシーケンス（> 5 Mb）、小規模ヒト低スルー全ゲノムシーケンス（≤ 5 Mb）

グローバル市場調査会社